3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Jed E. Rose: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers Nicotine Patch, Moclobemide - Nicotine Dependence | Phase 2 | Completed | Jed E. Rose | 76 | 2013-09-01 | 2017-08-23 |
| Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate Ganaxolone, Nicotine Patch - Smoking Cessation | Phase 2 | Completed | Jed E. Rose | 36 | 2013-06-01 | 2014-09-08 |
| The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers dehydroepiandrosterone (DHEA), pregnenolone, Placebo - Substance Withdrawal Syndrome | Phase 2 | Completed | Jed E. Rose | 22 | 2009-07-01 | 2012-09-21 |
Smoking Cessation (2) · Substance Withdrawal Syndrome (1) · Tobacco Use Disorder (1)
Nicotine (2) · Tobacco Use Cessation Devices (2) · Dehydroepiandrosterone (1) · Moclobemide (1) · Pregnenolone (1) · ganaxolone (1)
United States (3)
Jed E Rose, Ph.D. (3) · Christine Marx, M.D. (1)
P50DA027840 (2)